BOE Technology Group Co., Ltd.
BOE Technology Group Co., Ltd.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-26 | NCT07551778 | |
| NK Cell Injection for Advanced Solid Tumors | Advanced Solid Tumors | Not yet recruiting | Phase 1 | 2026-08-25 | NCT07784777 | |
| A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke | Acute Ischemic Stroke, androgen insensitivity syndrome, non-human animal, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 1 | 2026-06-05 | NCT07628933 | |
| Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System | brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorder | Recruiting | Not applicable | 2026-01-21 | NCT06783049 |